enterprises have received during the development process record the development process and pace of the enterprise, and are also an affirmation and recognition of the enterprise's strength and development. Looking back on 2022, Huaxi Biotech, a world-renowned biotechnology company and biomaterials company, has won a number of authoritative honors, becoming a testament to the company's high-quality development and witnessing its strategic pace of development.
Adhere to the underlying support of hard-core technology
Currently, our country is in a critical stage of comprehensively building national strategic scientific and technological strength. The report of the 20th National Congress of the Communist Party of China proposed to accelerate the implementation of innovation-driven development strategy and accelerate the realization of high-level scientific and technological self-reliance and self-reliance. Under the requirements of the new era, enterprises to strengthen research on key core technologies and increase the concentration of enterprises on global cutting-edge technologies are important measures to promote the implementation of the national science and technology innovation policy and build enterprise development advantages.
As a scientific and technological innovation enterprise, Bloomage Biotech has been insisting on taking scientific and technological innovation as the foundation of enterprise development for more than 20 years, continuously investing in basic research and applied basic research, constantly strengthening core technical barriers, and its scientific and technological strength has been repeatedly recognized.
In June 2022, Bloomage Biotech won the first prize of the 2021 Shandong Province Science and Technology Progress Award for its "Hyaluronic Acid Biosynthesis and Structural Modification Technology System Construction and Whole Industry Chain Application" project.
This award-winning project has carried out key technological innovations and research on hyaluronic acid biosynthesis, bioenzyme digestion, structural modification and other key technological problems in response to industry technical problems such as low initial yield of hyaluronic acid fermentation technology in my country, small production capacity , and large quality gap with foreign countries. The project has established an internationally advanced technology system and platform for high-yield hyaluronic acid industrial microbial fermentation, precise molecular weight control, and efficient structural modification technology. It has developed more than 200 specifications of pharmaceutical-grade, cosmetic-grade, and food-grade hyaluronic acid raw materials, multiple medical cosmetic fillers, new hemostatic dressings, cavity lubricants, functional foods, etc., as well as end products that break foreign market monopoly and fill domestic gaps. In the
project, scientific research and development and industrial implementation are fully integrated to realize the market application of hyaluronic acid from raw materials to medicine, medical beauty , personal care products, health food, etc., covering the public health and consumer industries, and innovatively extending to new application fields such as oral cavity, color cosmetics, household paper, pet supplies, etc., driving my country's hyaluronic acid industrial technology level to the forefront of the world, changing the global development and application pattern of hyaluronic acid.
This Shandong Provincial Science and Technology Award is a key award for innovations that are at the forefront of world science and technology and explore "no man's land" from "0 to 1", and encourage the improvement of source innovation capabilities. Winning this award proves Bloomage Biotech’s leading scientific and technological strength in the hyaluronic acid industry.
Following the first prize of Shandong Province Science and Technology Progress Award, in August 2022, Huaxi Biotech won many industry honors including China Light Industry Federation "Top Ten Enterprises in China's Fermentation Industry".
It is reported that " microbial fermentation " has always been one of Bloomage Biotech's important core technologies and basic research platforms, and is also one of the company's core advantages. Relying on its "microbial fermentation technology", Bloomage Biotech has achieved many industrial innovations and breakthroughs, leading industrial changes. For example, it was the first in China to produce hyaluronic acid on a large scale through microbial fermentation technology, the first in the world to realize the large-scale preparation of oligomeric hyaluronic acid by enzymatic digestion, and led two hyaluronic acid industrial revolutions.
relies on microbial fermentation technology and its advantages and experience in industrialization. In addition to hyaluronic acid, Huaxi Biotech can also produce a series of biologically active substances such as gamma-aminobutyric acid, ectoine, ergothioneine , brown rice fermentation filtrate, etc.
In addition, microbial fermentation technology is also an important foundation and support for the current development of synthetic biology technology. Relying on its advantages and experience in microbial fermentation technology and industrialization, Bloomage Biotech has a first-mover advantage in the field of synthetic biology and seizes industry opportunities.At present, Huaxi Biotech has become the "only" synthetic biology full industry chain enterprise in China that integrates the three major capabilities of synthetic biology: "R&D and innovation capabilities, pilot and industrial transformation capabilities, and market transformation capabilities."
embarking on the road of digital transformation development in the new era
On the one hand, it continues to consolidate the underlying foundation of technological innovation. On the other hand, Bloomage Biotech will continue to promote the digital transformation and upgrading of enterprises in 2022, and the quality and level of corporate management will continue to improve, becoming a benchmark enterprise for industrial development. In September 2022, Bloomage Biotech won the "Shandong Enterprise Management Innovation Achievement Award" for its "Innovative Practice of Whole Industry Chain Management Based on Digital Platform".
In recent years, my country's digital economy has accelerated and has become a strong driving force for economic development. The country's "Opinions on Supporting Shandong to Deepen the Conversion of Old and New Momentums to Promote Green, Low-carbon and High-Quality Development" proposes that "by 2027, industrial digital transformation will be fully promoted, and new technologies, new industries (300832), new business formats, and new models will become the main driving force for economic development" and other goals, emphasizing the important strategic significance of industrial digital transformation for economic development.
As a representative enterprise in the conversion of old and new kinetic energy in Shandong Province, a leading enterprise in creating characteristic industrial clusters in Shandong Province, and a benchmark enterprise in cultivating emerging industries in Jinan City, Bloomage Biotechnology has been adhering to Industry 4.0 as the starting point in recent years, continuing to upgrade the digital industry, achieving cost reduction and efficiency improvement, continuously deepening the automation and informatization reform of enterprise management, and assisting the development of Shandong Province's digital economic industry.
In addition, Huaxi Biofunctional Skin Care Products Workshop was also awarded the "Shandong Province Digital Workshop", the company's supply chain collaboration platform was selected as the "Shandong Province Industrial Internet Platform", and the company's modern operation and management capabilities have been repeatedly recognized.
Leading the way in promoting industrial science popularization
This year's national " Opinions on Further Strengthening the Popularization of Science and Technology in the New Era" proposed that the proportion of citizens with scientific literacy will reach 25% in 2035. In this regard, as an industry leader, Bloomage Biotech actively assumes the responsibilities of a leading enterprise, promotes the implementation of biotechnology science, and assists the development and upgrading of the industry.
In November 2022, Bloomage Biotech was selected into the fourth batch of Shandong Province Industrial Tourism Demonstration Bases. It is reported that Huaxi Bio-Industrial Tourism Demonstration Base is located in Jinan High-tech Zone. It is mainly composed of the World Hyaluronic Acid Museum, the world's first hyaluronic acid-themed museum, provincial digital workshops, exhibition halls and experience stores, comprehensively displaying the cultural characteristics of hyaluronic acid. At present, the base has become an important demonstration window for popular science education and academic exchanges in the global hyaluronic acid industry.
Among them, the World Hyaluronic Acid Museum is the first in the world and currently the only museum with the theme of hyaluronic acid. The museum is divided into five major exhibition units: "Hyaluronic acid - an indispensable substance for the human body, the origin of hyaluronic acid, the golden age of extraction methods, the birth and development of fermentation methods, and the world's largest hyaluronic acid R&D and production base". It also uses new technologies such as intelligent robot explanations and naked-eye 3D videos to vividly tell the development path of the hyaluronic acid industry in a scientific and modern way.
Since its opening in June 2020, the World Hyaluronic Acid Museum has successfully completed more than 2,000 batches of exhibition receptions, more than 100,000 visits including governments, institutions, enterprises, students, media, KOLs, social groups, etc., and more than 100 live broadcast events. It has become an important symbol of China's hyaluronic acid industry culture, further consolidates Huaxi's leading position in the bio-industry, and promotes China's hyaluronic acid development from industry-led to officially enter a new stage of culture-led.
In addition, at the end of August this year, Bloomage Biotech also completed the world's first "Synthetic Biology Science Museum" in Daxing, Beijing, to help popularize the scientific knowledge of synthetic biology. The science museum has been selected into the first batch of science popularization bases in Daxing District, Beijing, in 2022, becoming a new landmark and important milestone in China's biotechnology field.
In addition to the above-mentioned awards and honors in technological innovation, corporate management, and industry leadership, Bloomage Biotechnology has also won many industry honors and heavyweight awards this year, such as "China's 500 Most Valuable Brands", "National Cosmetics Industry Quality Leading Enterprise", "National Cosmetics Industry Quality Leading Brand", "National Quality Inspection Stable Qualified Products" and other industry honors and heavyweight awards, and has received a series of authoritative recognitions.
In the future, with the consumer market ushering in a new round of recovery, the bio-economy booming, and the high-quality driving role of science and technology in the economy, Bloomage Biotech's long-term development advantages are expected to be further released and create higher development value.
Huang Xi/Text
